BIO Professional Development

Through a curated network of education alliance partners, BIO offers industry professionals executive training and development resources for accelerating career growth

06/19/2026  -  06/21/2026  |  8:30 AM  -  5:00 PM  EDT

Business Development Fundamentals

The Business Development Fundamentals in-person course provides a foundation of the key skills that are required to execute a licensing transaction. With a focus on the biopharma industry, the course is taught by senior executives who have personal experience and expertise in transactional and intellectual property law; business development – both sell and buy sides; finance; alliance management; negotiation, and university technology transfer.  

 Previous attendees include professionals from many international institutions. A sample of companies include: 

  • Alkermes
  • NIH
  • American Society of Hematology
  • Gilead
  • Amgen
  • Merck National Taiwan University
  • Baylor College of Medicine
  • Novartis
  • Bluebird Biosciences
  • Queensland University of Technology
  • Biogen
  • Pfizer
  • Chinese University of Hong Kong
  • Sanofi
  • Eli Lilly
  • Takeda
  • Evotec
  • US Army Medical Research
  • Genentech
 

Who should take the course? 

  • Buy or sell-side business development or alliance management professionals with limited transactional experience 
  • Individuals interested in pursuing a career in business development, tech transfer, or alliance management 
  • Entrepreneurs 
  • Individuals who want to better understand the strategic role of business development in portfolio expansion or divestitures 

Interested in only registering for an in-person course in San Diego? If you do not plan to attend the Convention but would like to register for a course only, please see the registration instructions and use the registration code provided below. 

This three-day course will be held in person, June 19--21, 2026, in San Diego, Calif. To add this course to your Convention registration, click the Register button.

COURSE-ONLY REGISTRATION INSTRUCTIONS

  • Go to our REGISTRATION WEBSITE
  • Start New Registration
  • Enter your Email, First Name, Last Name, and Company. 
  • Select “Continue”
  • Provide requested personal information.
  • Enter the code 26CRONLY in the first “Registration Code” box and select “Apply Code.”
  • Select “Next”
  • Complete the required fields. 
  • Review your information on the “Review and Check Out” page and select “Next” for payment options and to complete the registration.
  • An e-mail confirmation will be sent automatically from the registration system. Please check your email filters if you do not receive them before contacting BIO.

If you have any questions about the registration process, please contact the registration team at customercare@bio.org or call (202) 962-6655. 

Have additional questions about the BIO Professional Development Program? Please email: courseshelp@bio.org

 

Instructors (click photos to view bios)

Takeaways

  • Types of strategic alliances and the process 
  • Term sheet development and contractual definitions 
  • Negotiation strategy 
  • Intellectual property and recent case studies 
  • Financial principles and asset valuation 
  • Alliance management
  • University licensing/tech transfer 
Course Price:
$3,190 USD
BIO Member Price:
$2,550 USD
Course Length:
3 days (June 19--21, 2026: San Diego, Calif.)
Course Level:
Introductory
Completion Period:
June 21, 2026
Course Format:
In Person

Certificate Requirements

  • Attend the entire in-person course
  • Complete course evaluation within two weeks of the course end date
Related Courses
FLIP

A digital strategy can no longer lie within a siloed digital or innovation team. It’s critical to integrate digital across the enterprise to maintain a competitive edge.

FLIP

Gain a systematic approach to producing a valuation that can be used in investment rounds, mergers/acquisitions, licensing deals or strategic development decisions in the pharma-biotech world...

FLIP

A panel of experts who have represented either the brand or generic side of intellectual property litigation in the pharmaceutical industry will present a three-part overview of these and related issues.

FLIP

Learn from experienced dealmakers a review of example models, a dissection of actual deals, have live participant interaction and Q&A opportunities.